Clinical Research Guidelines for Treatment of Osteoporosis with New Uyghur Medicine (Draft)
10.3969/j.issn.1005-5304.2017.10.001
- VernacularTitle:维药新药治疗骨质疏松症的临床研究指导原则(草案)
- Author:
Abudukelimu ABUDUWAILI
;
Aibai SILAFU
;
Pingshan WANG
;
Maitinuer YUSUFU
;
Wusiman MUHAMAITI
;
Hong ZHANG
;
Liansheng BAI
;
Jinfeng LI
;
Zhijian LI
;
Abuduaini ABUDUJILILI
;
Gongshu LI
;
Binglin LIU
;
Xiaojing PEI
;
Bei ZHOU
- Keywords:
osteoporosis;
Uyghur medicine;
clinical research guidelines
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2017;24(10):1-4
- CountryChina
- Language:Chinese
-
Abstract:
In this study, retrospective multi-center study on medical records of Uyghur medicine diagnosis and treatment program of osteoporosis was done and demographic, diagnostic, therapeutic, efficacy evaluation and nursing data and other information were collected. The main and secondary disease manifestations of osteoporosis were analyzed inductively. Osteoporosis was divided into 2 types in Uyghur medicine field, which were abnormal Savda type and abnormal Balgham type. Uighur medicine syndrome type standards of osteoporosis were established. Treatment efficacy was evaluated according to bone pain, bone density, life quality, and improvement of clinical symptoms and Uyghur medical symptoms. On this basis, in accordance with the technical requirements of the national drug review, the study developed clinical research guidelines for the treatment of osteoporosis with new Uyghur medicine (draft).
